EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Secondary anti‐viral prophylaxis in solid organ transplant recipients for the prevention of cytomegalovirus relapse: A systematic review and meta‐analysis

David Moynan iD, Eibhlin Higgins, Matteo Passerini, Larry J Prokop, Mohammad Hassan Murad, Raymund R Razonable iD

Transplant Infectious Disease · 2024

DOI: 10.1111/tid.14393 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von David Moynan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Mater Misericordiae University Hospital, Dublin, Ireland. Hauptthemen laut MEDLINE: Antiviral Agents, Cytomegalovirus Infections, Organ Transplantation, Secondary Prevention. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Infectious Disease Society of Ireland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in solid organ transplant recipients (SOTRs). Secondary prophylaxis (SP) is not routinely recommended by guidelines on the management of CMV in SOTR but may be considered in certain higher‐risk situations.

Methods

A comprehensive search of English language publications up to September 2023 was performed. The primary outcome was CMV relapse, defined as the recurrence of DNAemia or disease. Secondary outcomes included graft loss, mortality, and hematological toxicity. Meta‐analysis used the random‐effects model. The study protocol is registered in PROSPERO (no. CRD42022357028).

Results

Six retrospective comparative studies were included. A total of 520/727 (72%) of SOTR received SP with valganciclovir. The meta‐analysis did not demonstrate a significant difference in CMV relapse (odds ratio [OR] 1.15, 95% confidence interval [CI] 0.79–2.63). Heterogeneity between the studies was low ( I 2 = 0%, p = 0.57). SP was significantly associated with a reduction in mortality (OR 0.2, 95% CI 0.07–0.54) but not graft loss (OR 0.67, 0.17–2.63). There was no significant difference in CMV relapse among kidney‐specific SOTR (OR 1.38, 95% CI 0.65–2.96).

Conclusion

Evidence from six nonrandomized studies is limited and cannot support a recommendation for or against routine SP in SOTR treated for CMV infection. Awaiting prospective‐controlled trials, the decision about SP should depend on individualized risk‐profile assessments by experienced clinicians. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsCytomegalovirus InfectionsOrgan TransplantationSecondary PreventionTransplant RecipientsHumansCytomegalovirusRecurrenceRetrospective StudiesValganciclovir

Substanzen

Antiviral AgentsValganciclovir

Autor:innen und Institutionen

  • Department of Infectious Diseases, Mater Misericordiae University Hospital, Dublin, Ireland.
  • Department of Infectious Diseases, University Hospital Galway, Galway, Ireland.
  • Department of Pathophysiology and Transplantation, University of Milano, Milan, Italy.
  • Department of Infectious Diseases, ASST FBF SACCO Fatebenefratelli, Milan, Italy.
  • Mayo Clinic Libraries, Mayo Clinic, Rochester, Minnesota, USA.
  • Evidence-Based Practice Center, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: David Moynan, Raymund R Razonable

Förderung

  • Infectious Disease Society of Ireland

Zitieren

APA

Moynan, D., Higgins, E., Passerini, M., Prokop, L. J., Murad, M. H., & Razonable, R. R. (2024). Secondary anti‐viral prophylaxis in solid organ transplant recipients for the prevention of cytomegalovirus relapse: A systematic review and meta‐analysis. Transplant Infectious Disease. https://doi.org/10.1111/tid.14393

Vancouver

Moynan D, Higgins E, Passerini M, Prokop LJ, Murad MH, Razonable RR. Secondary anti‐viral prophylaxis in solid organ transplant recipients for the prevention of cytomegalovirus relapse: A systematic review and meta‐analysis. Transplant Infectious Disease. 2024. doi:10.1111/tid.14393

BibTeX
@article{Moynan2024,
  author = {Moynan, David and Higgins, Eibhlin and Passerini, Matteo and Prokop, Larry J and Murad, Mohammad Hassan and Razonable, Raymund R},
  title = {Secondary anti‐viral prophylaxis in solid organ transplant recipients for the prevention of cytomegalovirus relapse: A systematic review and meta‐analysis},
  journal = {Transplant Infectious Disease},
  year = {2024},
  doi = {10.1111/tid.14393}
}
Kostenlos starten →